» Articles » PMID: 39397243

Ferroptosis in Ischemic Stroke: Animal Models and Mechanisms

Overview
Journal Zool Res
Publisher Science Press
Date 2024 Oct 13
PMID 39397243
Authors
Affiliations
Soon will be listed here.
Abstract

Stroke is a major cause of death and disability worldwide, with the majority of cases resulting from ischemic events due to arterial occlusion. Current therapeutic approaches focus on rapid reperfusion through intravenous thrombolysis and intravascular thrombectomy. Although these interventions can mitigate long-term disability, reperfusion itself may induce neuronal injury. The exact mechanisms underlying neuronal damage following cerebral ischemia have yet to be reported. Recent research suggests that ferroptosis may play a significant role in post-ischemic neuronal death, which can be targeted to prevent neuronal loss. This review explores the three essential hallmarks of ferroptosis: the presence of redox-active iron, the peroxidation of polyunsaturated fatty acid-containing phospholipids, and the loss of lipid peroxide repair capacity. The involvement of ferroptosis in neuronal injury following ischemic stroke is also explored, along with an overview of ferroptosis-associated changes in different ischemic stroke animal models. Furthermore, recent therapeutic interventions targeting the ferroptosis pathway, as well as the opportunities, difficulties, and future directions of ferroptosis-targeted therapies in ischemic stroke, are discussed.

Citing Articles

DNA2 knockout aggravates cerebral ischemia/reperfusion injury by reducing postsynaptic Homer1a.

Ma T, Li Y, Ren P, Wang S, Liu X, Lv W Zool Res. 2025; 46(1):87-102.

PMID: 39846189 PMC: 11890998. DOI: 10.24272/j.issn.2095-8137.2024.269.

References
1.
Ye F, Garton H, Hua Y, Keep R, Xi G . The Role of Thrombin in Brain Injury After Hemorrhagic and Ischemic Stroke. Transl Stroke Res. 2020; 12(3):496-511. PMC: 8005504. DOI: 10.1007/s12975-020-00855-4. View

2.
Zhang J, Barasch N, Li R, Sapirstein A . Inhibition of cytosolic phospholipase A(2) alpha protects against focal ischemic brain damage in mice. Brain Res. 2012; 1471:129-37. DOI: 10.1016/j.brainres.2012.06.031. View

3.
Lapchak P, Zivin J . Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator. Stroke. 2003; 34(8):2013-8. DOI: 10.1161/01.STR.0000081223.74129.04. View

4.
Cheng G, Zhao W, Xin Y, Huang G, Liu Y, Li Z . Effects of ML351 and tissue plasminogen activator combination therapy in a rat model of focal embolic stroke. J Neurochem. 2021; 157(3):586-598. DOI: 10.1111/jnc.15308. View

5.
Dietrich R, Bradley Jr W . Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children. Radiology. 1988; 168(1):203-6. DOI: 10.1148/radiology.168.1.3380958. View